WINNIPEG, MB, Aug. 24, 2020 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, is reporting that early investigator sponsored clinical reports ...
WINNIPEG, MANITOBA--(Marketwire - Jan 8, 2013) - Medicure Inc. ("Medicure" or the "Company") (TSX VENTURE:MPH)(MCUJF), is pleased to announce that a supplemental new drug application (sNDA) for the ...
WINNIPEG, MANITOBA--(Marketwire - Sept. 26, 2012) - Medicure Inc. ("Medicure" or the "Company") (MPH.V)(MCUJ), is pleased to announce the development of a transdermal delivery formulation of its lead ...
WINNIPEG, Medicure Inc., a specialty pharmaceutical company, is pleased to announce that it has submitted an application to the U.S. Food and Drug Administration (FDA) for the introduction of a new ...
WINNIPEG, Medicure Inc., a specialty pharmaceutical company, is pleased to announce that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) to ...
Medicure announced that the Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Aggrastat (tirofiban HCl) injection to expand the product’s dosing time. The ...
WINNIPEG, MB, June 15, 2020 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, is pleased to announce that on ...
WINNIPEG, MANITOBA--(Marketwire - Jan. 30, 2012) - Medicure Inc. ("Medicure" or the "Company") (TSX VENTURE:MPH.V - News)(PINKSHEETS:MCUJ.PK - News) is pleased to announce its plans for a new clinical ...
WINNIPEG, MANITOBA--(Marketwire - Nov 5, 2012) - Medicure Inc. ("Medicure" or the "Company") (TSX VENTURE:MPH)(MCUJD), is pleased to announce that its wholly-owned subsidiary, Medicure Pharma, Inc., ...
Whitehouse Station, NJ and Sunnyvale, CA - It is rumored that Merck & Co is planning to license out its IIb/IIIa blocker antiplatelet agent, tirofiban (Aggrastat®) and that a possible licensee is ...
WINNIPEG, May 11, 2016 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, is pleased to announce that it has submitted an application to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results